New study: popular diabetes drug linked to dangerous heart problems

by DailyHealthPost EditorialSeptember 6, 2025

If you or someone you know takes medication for type 2 diabetes, this is a must-read. A groundbreaking new study has provided the clearest evidence yet that the diabetes drug rosiglitazone significantly increases your chance of suffering serious heart problems. This research, the most comprehensive of its kind, confirms long-held fears about the drug’s safety and may change how doctors treat the condition. 

Key Takeaways

• Significant Heart Risk: The study found that taking rosiglitazone is associated with a 33% higher risk of major cardiovascular events, including heart attack and heart failure.

• Most Comprehensive Evidence: This new analysis is the most complete to date, reviewing data from over 130 trials and more than 48,000 patients.

• Talk to Your Doctor: If you are currently taking rosiglitazone, it’s crucial to discuss these findings and your treatment options with your healthcare provider.

• A Call for Transparency: The findings highlight the critical need for open access to patient data in clinical trials to ensure drug safety.

A Long-Debated Drug Under the Microscope

You might know rosiglitazone as a medication used to help control blood sugar in people with type 2 diabetes. For years, however, it has been at the center of a major safety debate. Concerns that it could harm the heart led to its suspension in Europe and restricted use in the United States. Despite this, the evidence was never completely clear, leaving doctors and patients like you in a state of uncertainty.